市場調査レポート

商品コード

1647452

バクテリオファージの市場規模、シェア、成長分析：製品タイプ別、投与経路別、流通チャネル別、用途別、最終用途産業別、地域別 - 産業予測 2025年～2032年

Bacteriophage Market Size, Share, and Growth Analysis, By Product Type, By Route of Administration, By Distribution Channel, By Application, By End-use Industry, By Region - Industry Forecast 2025-2032

出版日: 2025年01月30日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 779,047円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 911,338円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,043,629円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.99円

全表示
概要
目次

概要

サンプル依頼リストに入れる

バクテリオファージの世界市場規模は2023年に4,960万米ドルと評価され、2024年の5,243万米ドルから2032年には8,169万米ドルに成長し、予測期間（2025-2032年）のCAGRは5.7%で成長する見通しです。

世界のバクテリオファージ市場は、抗生物質耐性や細菌感染に対する重要なソリューションとして台頭しています。細菌を特異的に標的とするウイルスであるバクテリオファージは、従来の抗生物質に代わる有望な選択肢です。市場の成長には、世界の健康脅威である抗生物質耐性菌に対する懸念の高まりが拍車をかけています。バクテリオファージはその高い特異性、細菌とともに進化する能力、有益な微生物叢に対する最小限の障害により、支持を集めています。ファージ療法は、前臨床試験と臨床試験の両方で有望な結果を示しており、特定の地域では規制当局の承認が市場の実行可能性を高めています。製薬会社と研究機関の協力関係が強化されるにつれ、市場は拡大し、個別化治療の選択肢を提供し、耐性リスクを低減することで、バクテリオファージは抗菌薬展望における重要な企業として位置づけられます。

北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング（2024年）
主な市場企業が採用した戦略
市場の最近の動向
企業の市場シェア分析（2024年）
主要企業の企業プロファイル
- 会社概要
- 製品ポートフォリオ分析
- セグメント別シェア分析
- 収益の前年比比較（2022-2024）

主要企業プロファイル

Intralytix（United States）
Proteon Pharmaceuticals（Poland）
Phagelux（China）
Micreos（Netherlands）
Eliava BioPreparations（Georgia）
Locus Biosciences（United States）
Pherecydes Pharma（France）
APS Biocontrol Ltd.（United Kingdom）
Qingdao Phagepharm Biotech（China）
Fixed-Phage Limited（United Kingdom）
Zeptometrix（United States）
Phage International, Inc.（United States）
Micromir（Russia）
Armata Pharmaceuticals, Inc.（United States）
Nextbiotics（United States）
InnoPhage, Ltd（Portugal）
TechnoPhage（Portugal）
Eligo Bioscience SA（France）
NPO Microgen（Russia）
Pharmex Group, LLC（Russia）

結論と推奨事項

Product Code: SQMIG35H2196

Global Bacteriophage Market size was valued at USD 49.6 million in 2023 and is poised to grow from USD 52.43 million in 2024 to USD 81.69 million by 2032, growing at a CAGR of 5.7% during the forecast period (2025-2032).

The global bacteriophage market is emerging as a vital solution to antibiotic resistance and bacterial infections. Bacteriophages, which are viruses that specifically target bacteria, present a promising alternative to conventional antibiotics. The market's growth is fueled by increasing concerns over antibiotic-resistant bacteria, which are a significant global health threat. With their high specificity, capacity to evolve alongside bacteria, and minimal disruption to beneficial microbiota, bacteriophages are gaining traction. Phage therapy has shown encouraging results in both preclinical and clinical trials, and regulatory approvals in certain regions are enhancing market viability. As collaboration between pharmaceutical companies and research institutions intensifies, the market is poised for expansion, providing personalized treatment options and reducing resistance risks, thereby positioning bacteriophages as critical players in the antimicrobial landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Bacteriophage market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Bacteriophage Market Segments Analysis

Global Bacteriophage Market is segmented by Product Type, Route of Administration, Distribution Channel, Application, End-use Industry and region. Based on Product Type, the market is segmented into Phage Probiotics and Phage Therapeutics. Based on Route of Administration, the market is segmented into Oral, Topical and Others. Based on Distribution Channel, the market is segmented into Retail Pharmacies, Hospital Pharmacies and Online Pharmacies. Based on Application, the market is segmented into Gastroenterology, Respiratory Infections Treatment, Skin Infection Treatment, Wound Prophylaxis and Urological Infection Treatment. Based on End-use Industry, the market is segmented into Hospitals, Specialty Clinics, Homecare and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Bacteriophage Market

The rising incidence of antibiotic-resistant bacterial infections is significantly boosting the demand for alternative treatment solutions. Bacteriophages, which are viruses specifically designed to target and eliminate certain bacteria, present a compelling option for tackling antibiotic-resistant strains and superbugs. With traditional antibiotics becoming less effective, the global bacteriophage market is experiencing growth driven by the necessity for novel and tailored therapeutic strategies. This shift towards bacteriophage therapy highlights the urgent need for innovative solutions in the face of mounting challenges posed by resistant bacteria, ultimately shaping the future of infectious disease management and treatment modalities.

Restraints in the Global Bacteriophage Market

The global bacteriophage market faces significant restraints primarily due to the regulatory challenges associated with the use of live viruses in bacteriophage therapy. These challenges stem from safety concerns that necessitate extensive testing and approval processes to ascertain the safety and efficacy of these products, often leading to time-consuming and expensive procedures. Additionally, the presence of regulatory uncertainties and discrepancies across various regions can further impede the growth and expansion of the market. As a result, these factors may limit the accessibility and acceptance of bacteriophage therapies, ultimately affecting market potential and development.

Market Trends of the Global Bacteriophage Market

The Global Bacteriophage market is witnessing a significant upward trend, propelled by a surging interest in phage therapy amid the escalating crisis of antibiotic resistance. As traditional antibiotics become less effective against harmful bacterial pathogens, the medical community is increasingly turning to bacteriophages, which specifically target and eliminate resistant bacteria. Advances in phage biology, innovative isolation techniques, and successful clinical case studies are enhancing the viability of phage therapy as a therapeutic alternative. This paradigm shift in treating bacterial infections suggests a robust future for the bacteriophage market, estimated to grow exponentially as it addresses unmet medical needs worldwide.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies

Global Bacteriophage Market Size by Product Type & CAGR (2025-2032)

Market Overview
Phage Probiotics
Phage Therapeutics

Global Bacteriophage Market Size by Route of Administration & CAGR (2025-2032)

Market Overview
Oral
Topical
Others

Global Bacteriophage Market Size by Distribution Channel & CAGR (2025-2032)

Market Overview
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies

Global Bacteriophage Market Size by Application & CAGR (2025-2032)

Market Overview
Gastroenterology
Respiratory Infections Treatment
Skin Infection Treatment
Wound Prophylaxis
Urological Infection Treatment

Global Bacteriophage Market Size by End-use Industry & CAGR (2025-2032)

Market Overview
Hospitals
Specialty Clinics
Homecare
Others

Global Bacteriophage Market Size & CAGR (2025-2032)

North America (Product Type, Route of Administration, Distribution Channel, Application, End-use Industry)
- US
- Canada
Europe (Product Type, Route of Administration, Distribution Channel, Application, End-use Industry)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product Type, Route of Administration, Distribution Channel, Application, End-use Industry)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product Type, Route of Administration, Distribution Channel, Application, End-use Industry)
- Brazil
- Rest of Latin America
Middle East & Africa (Product Type, Route of Administration, Distribution Channel, Application, End-use Industry)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Intralytix (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Proteon Pharmaceuticals (Poland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Phagelux (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Micreos (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eliava BioPreparations (Georgia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Locus Biosciences (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pherecydes Pharma (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
APS Biocontrol Ltd. (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Qingdao Phagepharm Biotech (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fixed-Phage Limited (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zeptometrix (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Phage International, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Micromir (Russia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Armata Pharmaceuticals, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nextbiotics (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
InnoPhage, Ltd (Portugal)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
TechnoPhage (Portugal)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eligo Bioscience SA (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NPO Microgen (Russia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pharmex Group, LLC (Russia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

バクテリオファージの市場規模、シェア、成長分析：製品タイプ別、投与経路別、流通チャネル別、用途別、最終用途産業別、地域別 - 産業予測 2025年～2032年

Bacteriophage Market Size, Share, and Growth Analysis, By Product Type, By Route of Administration, By Distribution Channel, By Application, By End-use Industry, By Region - Industry Forecast 2025-2032

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

バクテリオファージ市場規模：製品タイプ別& CAGR（2025-2032）

バクテリオファージ市場規模：投与経路別& CAGR（2025-2032）

バクテリオファージ市場規模：流通チャネル別& CAGR（2025-2032）

バクテリオファージ市場規模：用途別& CAGR（2025-2032）

バクテリオファージ市場規模：最終用途産業別& CAGR（2025-2032）

バクテリオファージ市場規模：地域別& CAGR（2025-2032）